TAVI Heart Valve Wins CE Mark
Published date : 20 November 2012
Article date : 20 November 2012
Medcitynews reports on CE Mark approval for St. Jude Medical's Portico TAVI system for patients who are too unwell to undergo open heart surgery to replace diseased heart valves.
The 23 mm Portico TAVI valveis described by the manufacturer as the 'only approved transcatheter valve that can be completely resheathed, repositioned at the implant site or retrieved before it is released from the delivery system.'
Apparently, the device was designed to address one of the more common problems with first generation TAVI valves – paravalvular leak, a post-operative complication where blood flows through a channel between the implanted heart valve and the cardiac tissue because the prosthetic valve has not been sealed properly.
The article says that a CE Mark for a 25 mm TAVI valve is anticipated by the end of the year.
Read the original article here.
An article was also published in Medgadget, on 21 November 2012.
